Join the Class Action Against Moderna, Inc. For Shareholders
Important Class Action Information for Moderna, Inc. Shareholders
Attention all shareholders of Moderna, Inc. (NASDAQ: MRNA). If you purchased shares during the specified class period, there is critical information you need to know about a class action lawsuit that could impact your rights as an investor.
Class Period Details
This class action pertains to purchases made from January 18, 2023, to June 25, 2024. If you are among those who acquired MRNA shares during this timeframe, you are encouraged to contact the firm about potentially being recognized as a lead plaintiff.
Allegations Against Moderna
It has been alleged that during the class period, Moderna made several materially false and misleading statements regarding their mRNA-1345 vaccine intended for respiratory syncytial virus. The lawsuit claims that the company overstated the effectiveness of this vaccine, leading investors to make decisions based on misleading information.
Overview of Misleading Statements
The allegations suggest that Moderna failed to disclose that the mRNA-1345 vaccine was not as effective as investors were led to believe. This overstatement of the clinical and commercial prospects of the vaccine implies that numerous public statements made by Moderna were false and misleading.
Key Deadlines for Shareholders
Mark your calendars: the deadline for joining this class action is October 8, 2024. It is essential to act swiftly to ensure your eligibility to participate.
Next Steps to Take
Once you register as a shareholder, you will gain access to a portfolio monitoring system that will provide updates regarding the status of the case. This service is complimentary with no obligations required from you to participate in the proceedings.
Why Choose The Gross Law Firm?
The Gross Law Firm is a well-respected national class action law firm dedicated to safeguarding investors’ rights. Their commitment lies in combating deceit and fraud targeted at investors, ensuring that companies uphold responsible practices while engaging positively in the business community.
Contact Information for The Gross Law Firm
If you are interested in this class action or have any inquiries, please reach out to The Gross Law Firm at:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
Frequently Asked Questions
What is the class period for the lawsuit?
The class period runs from January 18, 2023, to June 25, 2024.
How can I join the class action against Moderna?
Shareholders can register their information by contacting the firm to ensure their participation by the deadline of October 8, 2024.
What are the allegations against Moderna?
Moderna is accused of making false statements regarding the effectiveness of its mRNA-1345 vaccine, misleading investors about its clinical prospects.
What benefits do I get by joining the lawsuit?
Joining the class action entitles you to updates via a portfolio monitoring service at no cost, helping you stay informed about the case's progress.
Why should I trust The Gross Law Firm?
The Gross Law Firm is known for advocating for investor rights and has a strong track record in class action cases aimed at protecting investors from fraud.
About The Author
Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.